Clinical trials
Neuropathy clinical trials
Below are recruiting neuropathy clinical trials, each written for real people, not researchers. We’re tracking 274 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07126197Enrolling by invitation
Lymphovenous bypass for diabetic nerve pain
This study tests if a surgery called lymphovenous bypass can reduce nerve pain caused by diabetes. It may help people with diabetic peripheral neuropathy, even if they have foot ulcers.
TaipeiAges 20–80 - NCT05639478Recruiting
Foot care and exercise program for people with diabetes
This trial tests whether a structured foot-care and exercise program in primary care helps adults with diabetes. It may help you stay more active and reduce foot problems by teaching daily care and safe movement.
Limeira, São PauloAges 18 years+ - NCT07623668RecruitingPhase 3
Testing a new drug for sudden vision loss from nerve inflammation
This study tests whether a new medication called privosegtor can help restore vision in people who recently experienced sudden vision loss in one eye due to optic nerve inflammation. You would receive the study drug early after your symptoms start, when treatment may be most effective.
Livonia, MichiganAges 18–50 - NCT07745920Recruiting
An online program for depression in people with adpkd
This study tests an internet-based program to help manage depression symptoms in people with ADPKD. The program may be a convenient way to get support for your mood without traveling to a clinic.
Rochester, MinnesotaAges 18–70 - NCT06619860RecruitingPhase 2
VX-993 for diabetic nerve pain
This trial tests a new medicine called VX-993 for people with diabetes who have had nerve pain in both feet or legs for at least a year. The goal is to see if it reduces pain and is safe.
Cullman, AlabamaAges 18–80 - NCT05642611RecruitingPhase 3
Cooling and compression for nerve protection during chemotherapy
This study tests whether using cooling and/or compression on the arms or legs can prevent nerve damage that can happen from certain chemotherapy drugs. If you get eligible chemo soon, this may help lower the chance of painful numbness or tingling during treatment.
Birmingham, AlabamaAges 18 years+ - NCT05136976RecruitingPhase 3
Rituximab for anti-MAG neuropathy in specific patients
This Phase 3 study tests rituximab, an antibody medicine, for people with a particular type of nerve damage called anti-MAG–related demyelinating polyneuropathy. It aims to see if rituximab improves symptoms or function in patients who are considered “good responders.”
BrestAges 18 years+ - NCT04786977Recruiting
Measuring a nerve-related eye signal in children on vincristine
This study checks how children’s pupil responses look while they are receiving vincristine (a cancer medicine). The goal is to learn whether a simple eye measurement can reflect how the body is responding to treatment.
Washington D.C., District of ColumbiaAges 6–18 - NCT05600764Recruiting
Study of how TRPV4 nerve disease develops over time
This study looks at the natural history of TRPV4-related neuropathy—how it starts and changes over time. It may help doctors better understand the condition, especially for people with TRPV4 gene changes.
Baltimore, MarylandAges 3–80 - NCT02804438Recruiting
Pupil measurement checks in neurocritical care patients
This study collects normal (baseline) results from a handheld eye pupil camera (a pupillometer) used during routine neuro–intensive care checks. It may help clinicians better interpret these eye measurements in future patients.
Dallas, TexasAges Any age - NCT07120100Recruiting
TMS for nerve pain from cancer chemo in breast/gyne cancer survivors
This trial tests if transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can reduce nerve pain caused by chemotherapy in women who have had breast or gynecologic cancer. You may be eligible if you have ongoing nerve pain that hasn't been helped by standard pain medications.
Salt Lake City, UtahAges 18 years+ - NCT06464536Recruiting
Tight gloves for nerve protection during taxane chemo
This study tests whether wearing tight surgical gloves during taxane chemotherapy can help reduce nerve damage in the hands and feet. It may be a good fit if you have breast or urogenital cancer and are starting taxane treatment for the first time.
ZurichAges 18 years+ - NCT04451265Recruiting
MRI test study for suspected anterior optic nerve stroke
This study checks how well a special MRI scan (diffusion-weighted imaging) can identify a specific optic nerve problem called anterior ischemic optic neuropathy (when blood flow to the optic nerve is reduced). If you have symptoms that suggest this condition, the trial compares your MRI findings to doctors’ assessment to see if the scan helps confirm the diagnosis.
Lille, LilleAges 18 years+ - NCT07602387Recruiting
Capsaicin cream for chemo-related nerve pain in legs
This study tests whether an 8% capsaicin cream (a chili-pepper derived treatment) can help reduce nerve pain and numbness in the legs caused by cancer chemotherapy drugs (taxanes). The cream is applied directly to affected areas, and the research team will track whether it improves your symptoms and pain levels over time.
Boulogne-Billancourt, HAUTS DE SEINEAges 18 years+ - NCT06524609RecruitingPhase 1/Phase 2
Green tea extract for nerve damage from chemo
This trial tests whether EGCG (a natural compound found in green tea) can prevent or treat nerve damage caused by the chemotherapy drug Abraxane. It may help people with cancer who are suffering from moderate to severe nerve pain or numbness.
Jinan, ShandongAges 18 years+ - NCT07576179Recruiting
Foot Muscle Exercises for Diabetic Nerve Damage
This study tests whether special exercises that strengthen the small muscles in your foot and ankle can help improve balance, reduce fall risk, and ease walking difficulties caused by diabetic nerve damage (diabetic peripheral neuropathy). You'll be compared to a group doing different ankle and foot exercises.
Sargodha, Punjab ProvinceAges 50–75 - NCT06628908RecruitingPhase 3
Study of suzetrigine for painful diabetic nerve damage
This trial tests an experimental medicine called suzetrigine to see if it can safely reduce pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It might be an option if you have had daily pain in both legs and current treatments haven't worked well enough.
Anniston, AlabamaAges 18–80 - NCT07452081Recruiting
Sensory-motor therapy for postmenopausal nerve pain
This study tests a therapy that combines sensory and motor exercises to improve nerve function in women with postmenopausal polyneuropathy, a condition that causes numbness and tingling in the arms and legs. It aims to help those with type 2 diabetes who have had numbness for more than 4 months.
IsmailiaAges 45–55 - NCT07392229RecruitingPhase 2
Zanubrutinib for Anti-MAG Neuropathy
This trial tests whether the oral drug zanubrutinib can help people with anti-MAG antibody polyneuropathy, a nerve condition often linked to certain blood cancers. It aims to improve nerve symptoms by targeting the immune cells responsible.
Milan, MilanAges 18 years+ - NCT06158529Recruiting
High-frequency spinal cord stimulation for diabetic nerve pain
This trial tests if a special type of spinal cord stimulation (high-frequency SCS) can better relieve painful nerve damage caused by diabetes. If you have long-term burning, stabbing, or electric-shock-like pain in both legs, this treatment may help reduce that pain.
BeijingAges 18–80 - NCT07231419RecruitingPhase 3
Study of suzetrigine for diabetic nerve pain
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
Birmingham, AlabamaAges 18–80 - NCT07209514Enrolling by invitation
Testing a spinal cord stimulator for diabetic nerve pain in the legs
This trial is studying a device called the Medtronic Inceptiv™ Closed-Loop DTM Spinal Cord Stimulator to see if it can help reduce pain from diabetic peripheral neuropathy (nerve damage caused by diabetes) in the lower legs. It is for people whose pain has lasted at least 6 months and hasn't been helped by other treatments.
Grand Island, NebraskaAges 19 years+ - NCT06834685Recruiting
Laser therapy for nerve pain after chemotherapy
This study tests a special laser treatment (photobiomodulation) to reduce nerve pain caused by chemotherapy in cancer patients. If you have had nerve pain for at least 3 months after chemo and can attend twice-weekly sessions, this may help ease your pain.
Mougins, Alpes MaritimesAges 18 years+ - NCT04633655Recruiting
Study tests nerve side effects from certain chemotherapy drugs
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
Birmingham, AlabamaAges 18 years+
Hear when a new Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neuropathy?
- Yes. Clin2 currently lists 274 recruiting neuropathy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neuropathy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neuropathy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.